References
PhotoCure. PhotoCure — Second Quarter Results 2003. Media Release: 19 Aug 2003. Available from URL: http://www.photocure.com
PhotoCure ASA, Karl Storz GmbH & CO. KG. Collaboration agreement between PhotoCure and Karl Storz. Media Release: 8 Jul 2003. Available from URL: http://www.photocure.com
PhotoCure ASA. PhotoCure — Files First MAA for Hexvix® Cystoscopy. Media Release: 18 Dec 2002. Available from URL: http://www.photocure.com
PhotoCure ASA. PhotoCure — Hexvix® ?marketing application found fileable in 26 European countries. Media Release: 1 Dec 2004. Available from URL: http://www.photocure.com
PhotoCure ASA. PhotoCure ASA — First quarter results 2005. Media Release: 3 May 2005. Available from URL: http://www.photocure.com
PhotoCure ASA. Hexvix® ?presentation for Nordic Urologists. Media Release: 17 Jun 2003. Available from URL: http://www.photocure.com
PhotoCure ASA. Hexvix® ?improves treatment of bladder cancer patients. Media Release: 28 Mar 2003. Available from URL: http://www.photocure.com
Jichlinski P, Guillou L, Karlsen SJ, et al. Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer — a multicenter study. Journal of Urology 170: 226–229, No. 1, Jul 2003
Schmidbauer J, Witjes F, Schmeller N, et al. Improved detection urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. Journal of Urology 171: 135–138, No. 1, Jan 2004
PhotoCure ASA. PhotoCure announces positive phase II results for its Hexvix (R) product. Media Release [2 pages], 20 Aug 2001. Available from URL: http://www.photocure.com
PhotoCure ASA. PhotoCure — Positive Phase III Clinical Results for Hexvix®. Media Release: 3 Sep 2002. Available from URL: http://www.photocure.com
Rights and permissions
About this article
Cite this article
Hexyl Aminolevulinate. Drugs R D 6, 235–238 (2005). https://doi.org/10.2165/00126839-200506040-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200506040-00007